SELLAS Life Sciences (SLS) Inventory Average (2013 - 2015)
SELLAS Life Sciences (SLS) reported Inventory Average of $1.0 million for Q2 2015, up 160.81% year-over-year from $395500.0 in Q2 2014, and up 59.67% quarter-over-quarter from $646000.0 in Q1 2015.
SELLAS Life Sciences (SLS) Inventory Average (2013 - 2015) Analysis & Trends
SELLAS Life Sciences (SLS) has 3 years of Inventory Average data on file, last reported at $1.0 million in Q2 2015.
- Inventory Average for Q2 2015 came in at $1.0 million, up 160.81% year-over-year; the trailing twelve-month figure through Jun 2015 was $1.0 million (up 160.81% YoY), and the FY2014 annual result was $520500.0, changed N/A from the prior year.
- Inventory Average climbed to $1.0 million in Q2 2015 per SLS's latest filing, from $646000.0 in the prior quarter.
- Over five years, Inventory Average peaked at $1.0 million in Q2 2015 and troughed at $372000.0 in Q1 2014.
- A 3-year average of $529125.0 and a median of $423500.0 in 2013 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2014 and 2015: Inventory Average increased 13.64% in 2014, then surged 160.81% in 2015.
- A 3-year view of Inventory Average shows it stood at $405500.0 in 2013, then surged by 36.25% to $552500.0 in 2014, then soared by 86.7% to $1.0 million in 2015.
- Business Quant data shows SLS's Inventory Average at $1.0 million in Q2 2015, $646000.0 in Q1 2015, and $552500.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.03 Mn |
| Mar 31, 2015 | 646,000.00 |
| Dec 31, 2014 | 552,500.00 |
| Sep 30, 2014 | 441,500.00 |
| Jun 30, 2014 | 395,500.00 |
| Mar 31, 2014 | 372,000.00 |
| Dec 31, 2013 | 405,500.00 |
| Sep 30, 2013 | 388,500.00 |